Elin Aamdal
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival.
Journal: Oncoimmunology
Published: December 20, 2024
A simple automated assay format for measuring multiple immune checkpoint inhibitors.
Journal: Journal of pharmaceutical and biomedical analysis
Published: August 27, 2024
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination.
Journal: Journal of translational medicine
Published: August 10, 2022
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2022
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment.
Journal: ESMO open
Published: February 12, 2022
Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.
Journal: International journal of cancer
Published: May 07, 2021
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
Journal: Frontiers in immunology
Published: February 03, 2021
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.
Journal: Clinical and experimental immunology
Published: February 20, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026